Evaluation of Vancomycin Accumulation in Patients With Obesity.

Maha S AssadoonJeffrey C Pearson David W KubiakMary P KovacevicBrandon W Dionne

Published in: Open forum infectious diseases (2022)

Patients with obesity are likely to experience vancomycin accumulation within the first 10 days of therapy. Clinicians should use frequent monitoring of vancomycin and use caution when interpreting early concentrations in patients with obesity.

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
methicillin resistant staphylococcus aureus
type diabetes
weight gain
palliative care
adipose tissue
stem cells
staphylococcus aureus
bone marrow